Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.
Authors
Sjöström, L; Rissanen, A; Andersen, T; Boldrin, M; Golay, A; Koppeschaar, H P; Krempf, M
Abstract
We undertook a randomised controlled trial to assess the efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, in promoting weight loss and preventing weight regain in obese patients over a 2-year period.